Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial

Diabetes, Obesity & Metabolism
J SkovJ S Christiansen

Abstract

To investigate the effects of a single dose of 1.2 mg liraglutide, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, on key renal variables in patients with type 2 diabetes. The study was a placebo-controlled, double-blind, crossover trial in 11 male patients with type 2 diabetes. Measurements included (51) Cr-EDTA plasma clearance estimated glomerular filtration rate (GFR) and MRI-based renal blood flow (RBF), tissue perfusion and oxygenation. Liraglutide had no effect on GFR [95% confidence interval (CI) -6.8 to 3.6 ml/min/1.73 m(2) ] or on RBF (95% CI -39 to 30 ml/min) and did not change local renal blood perfusion or oxygenation. The fractional excretion of lithium increased by 14% (p = 0.01) and sodium clearance tended to increase (p = 0.06). Liraglutide increased diastolic and systolic blood pressure (3 and 6 mm Hg) and heart rate (2 beats per min; all p < 0.05). Angiotensin II (ANG II) concentration decreased by 21% (p = 0.02), but there were no effects on other renin-angiotensin system components, atrial natriuretic peptides (ANPs), methanephrines or excretion of catecholamines. Short-term liraglutide treatment did not affect renal haemodynamics but decreased the proximal tubular sodium reabsorption. Blood ...Continue Reading

References

Mar 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·A M KappelgaardJ Giese
Oct 1, 1990·Japanese Journal of Pharmacology·M KawamuraT Omae
Nov 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·J Bröchner-Mortensen
Aug 10, 2000·Magnetic Resonance Imaging·N KargerC Glüer
Jan 10, 2002·European Journal of Pharmacology·Carol MorenoRichard J Roman
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Jean-Pierre GutzwillerChristoph Beglinger
May 4, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Meike KörnerJean Claude Reubi
Jun 8, 2007·American Journal of Physiology. Renal Physiology·Akemi KatsuradaHiroyuki Kobori
Jul 4, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Adil E BharuchaPhillip A Low
Jan 20, 2009·Biochemical and Biophysical Research Communications·Kunio HirataTakashi Uzu
Sep 25, 2009·American Journal of Physiology. Renal Physiology·Luciene R Carraro-LacroixAdriana C C Girardi
Mar 5, 2011·Kidney International. Supplement·Peter Rossing, Dick de Zeeuw
May 20, 2011·American Journal of Physiology. Renal Physiology·Renato O CrajoinasAdriana C C Girardi
Feb 11, 2012·British Journal of Clinical Pharmacology·Buddhike MendisPeter Mansell
Jul 4, 2012·Microvascular Research·Yuji IshibashiSho-ichi Yamagishi
Mar 7, 2013·The Journal of Clinical Endocrinology and Metabolism·Jeppe SkovJens Sandahl Christiansen
Dec 12, 2013·Endocrine Connections·Jeppe SkovJens Sandahl Christiansen
Dec 24, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Allan J CollinsLawrence Agodoa
Jan 29, 2014·Journal of Magnetic Resonance Imaging : JMRI·Dinah S KhatirNiels H Buus
Mar 5, 2014·Frontiers in Endocrinology·Jeppe SkovJens Sandahl Christiansen
May 6, 2014·Reviews in Endocrine & Metabolic Disorders·Jeppe Skov
Sep 25, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·B J von ScholtenP Rossing
Feb 12, 2015·American Journal of Physiology. Endocrinology and Metabolism·Ali AsmarJens Bülow
Dec 5, 2015·Diabetes, Obesity & Metabolism·Marcel H A MuskietDaniël H van Raalte

❮ Previous
Next ❯

Citations

Jun 28, 2016·Cell Metabolism·Daniel J Drucker
Oct 23, 2016·Journal of Diabetes and Its Complications·Emilie Hein ZobelPeter Rossing
Oct 19, 2016·Diabetes, Obesity & Metabolism·Bernt J von ScholtenPeter Rossing
Jan 15, 2017·Cardiovascular Diabetology·Martin LorenzLawrence Blonde
Nov 29, 2016·Diabetes, Obesity & Metabolism·Ajay ChaudhuriParesh Dandona
Nov 18, 2017·Expert Opinion on Drug Discovery·Matthew D Breyer, Matthias Kretzler
Jul 10, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ruben RodriguezRudy M Ortiz
Aug 16, 2018·American Journal of Physiology. Renal Physiology·Brad P DieterKatherine R Tuttle
Oct 26, 2018·American Journal of Physiology. Renal Physiology·Lennart TonneijckDaniël H van Raalte
Feb 2, 2017·Journal of the American Society of Nephrology : JASN·Lennart TonneijckJaap A Joles
Jan 4, 2018·Endocrine Connections·Signe FrøssingJens Faber
Mar 6, 2019·The Journal of Clinical Endocrinology and Metabolism·Ali AsmarJens Bülow
Sep 5, 2017·Nature Reviews. Nephrology·Marcel H A MuskietDaniël H van Raalte
Jun 4, 2019·Expert Opinion on Therapeutic Targets·Annabelle M WarrenMark E Cooper
Dec 17, 2019·American Journal of Physiology. Renal Physiology·Aleksander Vauvert R Hviid, Charlotte M Sørensen
Jan 9, 2020·Diabetes, Obesity & Metabolism·Nienke M A IdzerdaHiddo J L Heerspink
Oct 22, 2019·Endocrine Reviews·Yuliya LytvynDavid Z I Cherney
Nov 13, 2019·Current Opinion in Nephrology and Hypertension·Michaël J B van Baar, Daniël H van Raalte
May 12, 2020·American Journal of Physiology. Renal Physiology·Elisa P JensenCharlotte M Sorensen
Jul 21, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Peng ChenXianwei Wang
Aug 31, 2017·The New England Journal of Medicine·Johannes F E MannUNKNOWN LEADER Steering Committee and Investigators
Aug 7, 2019·Therapeutic Advances in Endocrinology and Metabolism·Michaël J B van BaarDaniël H van Raalte
Oct 1, 2020·BMC Endocrine Disorders·Flavio A Cadegiani
Feb 6, 2020·Journal of the Endocrine Society·Emilie Balk-MøllerHannelouise Kissow
Mar 19, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Win L YinThinzar Min
Mar 27, 2020·International Journal of Molecular Sciences·Devang M PatelMark E Cooper
Aug 24, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Taichi Nagahisa, Yoshifumi Saisho
Nov 27, 2019·Molecular Metabolism·T D MüllerM H Tschöp
Apr 20, 2021·Endocrinology and Metabolism·Jason F LeeDavid Z I Cherney
Jul 20, 2021·Endocrinology, Diabetes & Metabolism·Katrine Dahl BjørnholmCharles Pyke
Apr 22, 2021·Transplant International : Official Journal of the European Society for Organ Transplantation·Lale A ErtugluMehmet Kanbay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.